Streetbeat News

Revenues

IEF

The U.S. economy grew at an annualized rate of 1.3% in Q1 2024, down from an initial estimate of 1.6%. This slower growth, driven by reduced consumer spending, has eased Treasury yields and raised bond ETFs like the iShares 7-10 Year Treasury Bond ETF (IEF). Economists are divided on whether this will prompt the Federal Reserve to cut interest rates, with some suggesting that inflation remains a significant concern.

Portfolio Pulse from Piero Cingari

May 30, 2024 | 3:25 pm

LLY

NVO

Goldman Sachs analysts have re-rated Eli Lilly (LLY) and Novo Nordisk (NVO), projecting the weight-loss drug market to reach $130 billion by 2030. Eli Lilly's price target was raised to $785, while Novo Nordisk's was reiterated at $156. Both companies are expected to maintain a dominant market share.

Portfolio Pulse from Anusuya Lahiri

May 30, 2024 | 3:17 pm

CAL

Caleres, Inc. (NYSE:CAL) shares are trading lower after the company reported Q1 results that missed analyst expectations. Earnings per share were 88 cents, below the expected 91 cents, and revenues were $659.198 million, missing the $665.45 million consensus. Despite a 5.2% reduction in inventory and a slight increase in gross margin, net sales and operating earnings declined year over year. The company expects flat to 2% growth in net sales for FY 2024 and aims to reduce debt significantly by 2026.

Portfolio Pulse from Nabaparna Bhattacharya

May 30, 2024 | 3:12 pm

CAE

CAE Defense & Security has been awarded a $250 million contract by General Atomics to support Canada's MQ-9B SkyGuardian RPAS program.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 3:03 pm

CHH

Eight financial analysts have shared their evaluations of Choice Hotels Intl (NYSE:CHH) over the past three months, showing a mix of bullish and bearish perspectives. The average 12-month price target has increased to $133.88, reflecting a 3.88% rise from the previous target. Analysts have adjusted their ratings and price targets, with some lowering and others raising their estimates. Key financial metrics indicate challenges in revenue growth and asset utilization, but strong return on equity.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 3:00 pm

PLTR

The article provides a comprehensive analysis of Palantir Technologies (NYSE:PLTR) compared to its competitors in the software industry. Key financial metrics such as P/E, P/B, P/S, ROE, EBITDA, gross profit, and revenue growth are examined. Palantir shows a high P/E ratio, low P/B ratio, high P/S ratio, and lower ROE, EBITDA, and gross profit compared to industry averages. However, it has a strong revenue growth rate and a favorable debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 3:00 pm

CDNS

Cadence Design Systems (NASDAQ:CDNS) has significantly outperformed the market over the past decade, delivering an average annual return of 33.1%. A $1000 investment in CDNS 10 years ago would be worth $17,512.17 today. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 3:00 pm

EQIX

Equinix (NASDAQ:EQIX) has outperformed the market over the past 10 years with an average annual return of 14.31%, resulting in a $100 investment growing to $387.03. The company currently has a market capitalization of $72.26 billion.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 3:00 pm

GME

The article provides a comprehensive analysis of GameStop (NYSE:GME) compared to its competitors in the Specialty Retail industry. Key financial metrics indicate that GameStop is overvalued relative to its peers, with high P/E, P/B, and P/S ratios. However, it shows lower profitability and growth potential, with lower ROE, EBITDA, gross profit, and revenue growth.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 3:00 pm

AAPL

HPE

NTAP

PSTG

SMCI

The article provides a comprehensive comparison of Super Micro Computer (NASDAQ: SMCI) against its competitors in the Technology Hardware, Storage & Peripherals industry. Key financial metrics such as P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth are analyzed. The analysis suggests that SMCI is undervalued compared to its peers but faces operational challenges, although it shows strong revenue growth and a favorable debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 3:00 pm